Nontuberculous mycobacteria (NTM) infection prevalence has increased among those with cystic fibrosis (CF), impacting 1 out of 10 people with CF. In this podcast, Amy Leitman, JD, shares what nontuberculous mycobacterial (NTM) lung disease is, and why its resistance to many treatments poses serious risks to those living with cystic fibrosis. Amy is President of NTM Info & Research (NTMir), a national non-profit organization dedicated to supporting patients with NTM through global respiratory health awareness (including World NTM Awareness Day on August 4), patient advocacy and policy reform.
For more information on NTMir and World NTM Awareness Day: NTMir Facebook, Instagram (@ntminfo), X (@ntminfo), and LinkedIn.
Click here to donate to CFRI and support the cystic fibrosis community worldwide: https://cfri.app.neoncrm.com/forms/donation
Your thoughts are valuable to us and will help with future podcast planning! Respond to our short survey https://www.surveymonkey.com/r/MPYLX9F, and you’ll be entered in our quarterly drawing for a $25 Etsy gift card. Winners notified by email.
Funding for CF Community Voices 2025 has been provided to date by Viatris and Vertex Pharmaceuticals.

Ver todos los episodios